Profesionales:

Javier del Pino Montes

Javier del Pino Montes

Perfiles de Investigación:

Puestos de trabajo

No hay puestos de trabajo disponibles.

Observaciones del puesto

Publicaciones más recientes

Long‐Term Treatment and Effect of Discontinuation of Calcifediol in Postmenopausal Women with Vitamin D Deficiency: A Randomized Trial (referencia en la web)
Reply to Calcifediol Is Not Superior to Cholecalciferol in Improving Vitamin D Status in Postmenopausal Women (referencia en la web)
Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry (referencia en la web)
Calcifediol is superior to cholecalciferol in improving vitamin D status in postmenopausal women: a randomized trial (referencia en la web)
A mutation in p62 protein (p. R321C), associated to Paget’s disease of bone, causes a blockade of autophagy and an activation of NF-kB pathway (referencia en la web)
Characteristics of Early Paget’s Disease in SQSTM1 Mutation Carriers: Baseline Analysis of the ZiPP Study Cohort (referencia en la web)
The complexity of classifying ANCA-associated small-vessel vasculitis in actual clinical practice: data from a multicenter retrospective survey (referencia en la web)
Reducing or Maintaining the Dose of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis in Clinical Remission: A Randomized, Open-Label Trial (referencia en la web)
Objectives and methodology of BIOBADASER phase III (referencia en la web)
Factors associated with long-term retention of treatment with golimumab in a real-world setting: an analysis of the Spanish BIOBADASER registry (referencia en la web)
The next step after anti-osteoporotic drug discontinuation: an up-to-date review of sequential treatment (referencia en la web)
Clinical and therapeutic management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: RADAR study (referencia en la web)
Zoledronate in the prevention of Paget’s (ZiPP): Protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget’s disease of bone (referencia en la web)
SER recommendations on the use of biological drugs in primary Sjögren’s syndrome (referencia en la web)
Polymorphisms in genes implicated in base excision repair (BER) pathway are associated with susceptibility to Paget’s disease of bone (referencia en la web)
Protocol for the preventive treatment of osteoporosis in systemic autoim mune diseases (referencia en la web)
Complex regional pain syndrome (referencia en la web)
Protocolo de tratamiento preventivo de la osteoporosis en las enfermedades sistémicas autoinmunes (referencia en la web)
Síndrome de dolor regional complejo (referencia en la web)
Protocolo diagnóstico y tratamiento de la osteomalacia (referencia en la web)
Diagnostic and treatment protocol of osteomalacia (referencia en la web)
Identification of a novel locus on chromosome 2q13, which predisposes to clinical vertebral fractures independently of bone density (referencia en la web)
Microbiota intestinal y hueso (referencia en la web)
Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics (referencia en la web)
Diagnostic Value and Validity of Early Spondyloarthritis Features: Results From a National Spanish Cohort (referencia en la web)
Eficacia, eficiencia y efectividad en el tratamiento multidimensional de la esquizofrenia: proyecto Rethinking (referencia en la web)
Bisphosphonates for Paget’s disease of bone in adults (referencia en la web)
Proangiogenic gene polymorphisms are associated with susceptibility to Paget’s disease of bone and with its clinical features (referencia en la web)
Clinical and Genetic Advances in Paget’s Disease of Bone: a Review (referencia en la web)